Problem statement: Answer the MCQ question.
Question: Which compound exhibits a 2.108\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) CC1CN(C(=O)CSc2nc(-c3ccc(F)cc3)cs2)CC(C)O1
b.) O=C(c1cc2cc([N+](=O)[O-])ccc2oc1=O)N1CCOCC1
c.) COCCNC(=O)CCCn1c(=O)c2cc(OC)c(OC)cc2n(CC(=O)Nc2ccc(F)cc2)c1=O
d.) CN1CCN(S(=O)(=O)c2ccc(N(C)Cc3cccc(F)c3)nc2)CC1
e.) COc1ccc(CN2C(=NC(=O)C3CC3)SC3CS(=O)(=O)CC32)cc1OC
Answer: e. COc1ccc(CN2C(=NC(=O)C3CC3)SC3CS(=O)(=O)CC32)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CN2C(=NC(=O)C3CC3)SC3CS(=O)(=O)CC32)cc1OC
COc1ccc(CN2C(=NC(=O)C3CC3)SC3CS(=O)(=O)CC32)cc1OC
N-[3-[(3,4-dimethoxyphenyl)methyl]-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]cyclopropanecarboxamide